Edwards, Bryan B <br/><br/>
Biochemically engineered stromal cell-derived factor 1-alpha analog increases perfusion in the ischemic hind limb.  [electronic resource] 

 -  Journal of vascular surgery  10 2016 
 - 1093-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1097-6809 
<br/><br/><label>Standard No.: </label>10.1016/j.jvs.2015.06.140  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inducing Agents--administration & dosage<br/>Animals<br/>Blood Flow Velocity<br/>Chemokine CXCL12--administration & dosage<br/>Disease Models, Animal<br/>Granulocyte-Macrophage Colony-Stimulating Factor--pharmacology<br/>Hindlimb<br/>Inflammation Mediators--metabolism<br/>Injections, Intramuscular<br/>Ischemia--drug therapy<br/>Male<br/>Neovascularization, Physiologic--drug effects<br/>Protein Engineering<br/>Quadriceps Muscle--blood supply<br/>Rats, Wistar<br/>Recombinant Proteins--pharmacology<br/>Recovery of Function<br/>Regional Blood Flow<br/>Time Factors<br/>Vascular Endothelial Growth Factor A--genetics